Cargando…

Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey

BACKGROUND: The prevalence of hyperuricemia, gout, and heart failure (HF) is on the rise, and these conditions often share similar risk factors. The present study aimed to evaluate the relationship among hyperuricemia, gout, HF, and all-cause mortality. METHODS: The data on nonpregnant participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yingdong, Cao, Yu, Han, Xinxin, Di, Hong, Yin, Yue, Wu, Juan, Zhang, Yun, Zeng, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339518/
https://www.ncbi.nlm.nih.gov/pubmed/37438830
http://dx.doi.org/10.1186/s12967-023-04307-z
_version_ 1785071862136438784
author Han, Yingdong
Cao, Yu
Han, Xinxin
Di, Hong
Yin, Yue
Wu, Juan
Zhang, Yun
Zeng, Xuejun
author_facet Han, Yingdong
Cao, Yu
Han, Xinxin
Di, Hong
Yin, Yue
Wu, Juan
Zhang, Yun
Zeng, Xuejun
author_sort Han, Yingdong
collection PubMed
description BACKGROUND: The prevalence of hyperuricemia, gout, and heart failure (HF) is on the rise, and these conditions often share similar risk factors. The present study aimed to evaluate the relationship among hyperuricemia, gout, HF, and all-cause mortality. METHODS: The data on nonpregnant participants aged ≥ 20 years with or without hyperuricemia, gout, and HF from the National Health and Nutrition Examination Survey 2001–2018 and 2007–2018 were included in this study. The binary logistic regression, Kaplan–Meier curve, Cox proportional-hazards model, and restricted cubic spline analysis were employed to evaluate the relationship among hyperuricemia, gout, HF, and all-cause mortality. RESULTS: Of 204,179,060 and 223,702,171 weighted eligible participants, 40,044,228 (19.6%) and 9,158,600 (4.1%) had hyperuricemia and gout, respectively. Older age, diabetes, stroke, and coronary artery disease were the risk factors for HF among patients with hyperuricemia and gout. The median survival time was 7.00 years and 6.25 years and the 5-year survival rate was 59.9% and 55.9% for patients with HF and hyperuricemia and those with HF and gout, respectively. Patients with hyperuricemia or gout were 2.46 and 2.35 times more likely to have HF and 1.37 and 1.45 times more likely to experience all-cause mortality compared with those who did not exhibit these conditions. The restricted cubic spline showed a nonlinear correlation between uric acid levels and HF and a J-shaped correlation between uric acid levels and all-cause mortality. CONCLUSIONS: Ambulatory patients with hyperuricemia or gout were more likely to have HF compared with those without hyperuricemia or gout. Patients with HF with hyperuricemia or gout were more likely to experience all-cause mortality in the long-term follow-up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04307-z.
format Online
Article
Text
id pubmed-10339518
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103395182023-07-14 Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey Han, Yingdong Cao, Yu Han, Xinxin Di, Hong Yin, Yue Wu, Juan Zhang, Yun Zeng, Xuejun J Transl Med Research BACKGROUND: The prevalence of hyperuricemia, gout, and heart failure (HF) is on the rise, and these conditions often share similar risk factors. The present study aimed to evaluate the relationship among hyperuricemia, gout, HF, and all-cause mortality. METHODS: The data on nonpregnant participants aged ≥ 20 years with or without hyperuricemia, gout, and HF from the National Health and Nutrition Examination Survey 2001–2018 and 2007–2018 were included in this study. The binary logistic regression, Kaplan–Meier curve, Cox proportional-hazards model, and restricted cubic spline analysis were employed to evaluate the relationship among hyperuricemia, gout, HF, and all-cause mortality. RESULTS: Of 204,179,060 and 223,702,171 weighted eligible participants, 40,044,228 (19.6%) and 9,158,600 (4.1%) had hyperuricemia and gout, respectively. Older age, diabetes, stroke, and coronary artery disease were the risk factors for HF among patients with hyperuricemia and gout. The median survival time was 7.00 years and 6.25 years and the 5-year survival rate was 59.9% and 55.9% for patients with HF and hyperuricemia and those with HF and gout, respectively. Patients with hyperuricemia or gout were 2.46 and 2.35 times more likely to have HF and 1.37 and 1.45 times more likely to experience all-cause mortality compared with those who did not exhibit these conditions. The restricted cubic spline showed a nonlinear correlation between uric acid levels and HF and a J-shaped correlation between uric acid levels and all-cause mortality. CONCLUSIONS: Ambulatory patients with hyperuricemia or gout were more likely to have HF compared with those without hyperuricemia or gout. Patients with HF with hyperuricemia or gout were more likely to experience all-cause mortality in the long-term follow-up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04307-z. BioMed Central 2023-07-12 /pmc/articles/PMC10339518/ /pubmed/37438830 http://dx.doi.org/10.1186/s12967-023-04307-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Han, Yingdong
Cao, Yu
Han, Xinxin
Di, Hong
Yin, Yue
Wu, Juan
Zhang, Yun
Zeng, Xuejun
Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
title Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
title_full Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
title_fullStr Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
title_full_unstemmed Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
title_short Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
title_sort hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the national health and nutrition examination survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339518/
https://www.ncbi.nlm.nih.gov/pubmed/37438830
http://dx.doi.org/10.1186/s12967-023-04307-z
work_keys_str_mv AT hanyingdong hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT caoyu hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT hanxinxin hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT dihong hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT yinyue hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT wujuan hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT zhangyun hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey
AT zengxuejun hyperuricemiaandgoutincreasedtheriskoflongtermmortalityinpatientswithheartfailureinsightsfromthenationalhealthandnutritionexaminationsurvey